chrX-102714932-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001004051.4(GPRASP2):āc.63G>Cā(p.Glu21Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00236 in 1,211,335 control chromosomes in the GnomAD database, including 5 homozygotes. There are 889 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.0014 ( 0 hom., 45 hem., cov: 24)
Exomes š: 0.0025 ( 5 hom. 844 hem. )
Consequence
GPRASP2
NM_001004051.4 missense
NM_001004051.4 missense
Scores
5
12
Clinical Significance
Conservation
PhyloP100: 0.752
Genes affected
GPRASP2 (HGNC:25169): (G protein-coupled receptor associated sorting protein 2) The protein encoded by this gene is a member of a family that regulates the activity of G protein-coupled receptors (GPCRs). The encoded protein has been shown to be capable of interacting with several GPCRs, including the M1 muscarinic acetylcholine receptor and the calcitonin receptor. Several transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, May 2010]
ARMCX5-GPRASP2 (HGNC:42000): (ARMCX5-GPRASP2 readthrough) This locus represents naturally occurring readthrough transcription among the adjacent armadillo repeat containing, X-linked 5 (ARMCX5), G protein-coupled receptor associated sorting proteins 1 and 2 (GPRASP1 and GPRASP2), basic helix-loop-helix family member b9 (BHLHB9), and long intergenic non-protein coding RNA 630 (LINC00630) genes on chromosome X. Transcripts may make use of multiple alternative promoters and polyadenylation signals in this region. Readthrough transcripts may produce proteins identical to the proteins encoded by GPRASP2 or BHLHB9. [provided by RefSeq, Apr 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0074768364).
BS2
High Hemizygotes in GnomAd4 at 45 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GPRASP2 | NM_001004051.4 | c.63G>C | p.Glu21Asp | missense_variant | 5/5 | ENST00000483720.7 | |
ARMCX5-GPRASP2 | NR_146584.3 | n.795+666G>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GPRASP2 | ENST00000483720.7 | c.63G>C | p.Glu21Asp | missense_variant | 5/5 | 2 | NM_001004051.4 | P1 | |
ARMCX5-GPRASP2 | ENST00000652409.1 | c.-756+666G>C | intron_variant | P1 |
Frequencies
GnomAD3 genomes AF: 0.00143 AC: 162AN: 113100Hom.: 0 Cov.: 24 AF XY: 0.00128 AC XY: 45AN XY: 35234
GnomAD3 genomes
AF:
AC:
162
AN:
113100
Hom.:
Cov.:
24
AF XY:
AC XY:
45
AN XY:
35234
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00124 AC: 227AN: 183363Hom.: 0 AF XY: 0.00125 AC XY: 85AN XY: 67813
GnomAD3 exomes
AF:
AC:
227
AN:
183363
Hom.:
AF XY:
AC XY:
85
AN XY:
67813
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00246 AC: 2697AN: 1098235Hom.: 5 Cov.: 31 AF XY: 0.00232 AC XY: 844AN XY: 363589
GnomAD4 exome
AF:
AC:
2697
AN:
1098235
Hom.:
Cov.:
31
AF XY:
AC XY:
844
AN XY:
363589
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00143 AC: 162AN: 113100Hom.: 0 Cov.: 24 AF XY: 0.00128 AC XY: 45AN XY: 35234
GnomAD4 genome
AF:
AC:
162
AN:
113100
Hom.:
Cov.:
24
AF XY:
AC XY:
45
AN XY:
35234
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
11
ALSPAC
AF:
AC:
14
ESP6500AA
AF:
AC:
2
ESP6500EA
AF:
AC:
24
ExAC
AF:
AC:
172
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 17, 2022 | The c.63G>C (p.E21D) alteration is located in exon 5 (coding exon 1) of the GPRASP2 gene. This alteration results from a G to C substitution at nucleotide position 63, causing the glutamic acid (E) at amino acid position 21 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
GPRASP2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 16, 2021 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;T
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T;.
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;M
MutationTaster
Benign
N;N;N
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Uncertain
D;D;D
Polyphen
P;P;P
Vest4
MutPred
Gain of ubiquitination at K16 (P = 0.1079);Gain of ubiquitination at K16 (P = 0.1079);Gain of ubiquitination at K16 (P = 0.1079);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at